216 related articles for article (PubMed ID: 22302680)
21. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression.
Shen KH; Hung JH; Chang CW; Weng YT; Wu MJ; Chen PS
Chem Biol Interact; 2017 Apr; 268():129-135. PubMed ID: 28283413
[TBL] [Abstract][Full Text] [Related]
22.
Qin L; Liu L; Wu Y; Chen Y; Wu Y; Luo H; Xi Y; Xiu F; Hu J; Chen L; Wu N; He J; Zeng Y; Zhu C; You X
Virulence; 2022 Dec; 13(1):1270-1284. PubMed ID: 35892136
[TBL] [Abstract][Full Text] [Related]
23. Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling.
Kitajima S; Miki T; Takegami Y; Kido Y; Noda M; Hara E; Shamma A; Takahashi C
Oncogene; 2011 Feb; 30(6):737-50. PubMed ID: 20890302
[TBL] [Abstract][Full Text] [Related]
24. Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries.
Palladini G; Di Pasqua LG; Croce AC; Ferrigno A; Vairetti M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139236
[TBL] [Abstract][Full Text] [Related]
25. Rat forming incisor requires a rigorous ECM remodeling modulated by MMP/RECK balance.
Paiva KB; Zambuzzi WF; Accorsi-Mendonça T; Taga R; Nunes FD; Sogayar MC; Granjeiro JM
J Mol Histol; 2009 Jun; 40(3):201-7. PubMed ID: 19838811
[TBL] [Abstract][Full Text] [Related]
26. Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.
Russell JJ; Grisanti LA; Brown SM; Bailey CA; Bender SB; Chandrasekar B
Cell Signal; 2021 Jul; 83():109993. PubMed ID: 33781845
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs.
Fan X; Wang E; Wang X; Cong X; Chen X
Exp Mol Pathol; 2014 Apr; 96(2):242-9. PubMed ID: 24594117
[TBL] [Abstract][Full Text] [Related]
28. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis.
Wang L; Wang Q; Li HL; Han LY
Asian Pac J Cancer Prev; 2013; 14(3):2113-8. PubMed ID: 23679328
[TBL] [Abstract][Full Text] [Related]
29. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
[TBL] [Abstract][Full Text] [Related]
30. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
[TBL] [Abstract][Full Text] [Related]
31. Basigin-mediated gene expression changes in mouse uterine stromal cells during implantation.
Chen L; Belton RJ; Nowak RA
Endocrinology; 2009 Feb; 150(2):966-76. PubMed ID: 18832103
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase inhibitor RECK expression in canine tumors.
Takagi S; Kato Y; Asano K; Ohsaki T; Bosnakovski D; Hoshino Y; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 2005 Aug; 67(8):761-7. PubMed ID: 16141662
[TBL] [Abstract][Full Text] [Related]
33. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.
Oh J; Takahashi R; Kondo S; Mizoguchi A; Adachi E; Sasahara RM; Nishimura S; Imamura Y; Kitayama H; Alexander DB; Ide C; Horan TP; Arakawa T; Yoshida H; Nishikawa S; Itoh Y; Seiki M; Itohara S; Takahashi C; Noda M
Cell; 2001 Dec; 107(6):789-800. PubMed ID: 11747814
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma.
Wang L; Ge J; Ma T; Zheng Y; Lv S; Li Y; Liu S
Tumour Biol; 2015 Dec; 36(12):9511-6. PubMed ID: 26130413
[TBL] [Abstract][Full Text] [Related]
35. Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.
Zhang Y; Cheng S; Zhang G; Ma W; Liu Y; Zhao R; Zhang Q; Pang D
Cancer Sci; 2012 Jun; 103(6):1084-9. PubMed ID: 22404079
[TBL] [Abstract][Full Text] [Related]
36. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
[TBL] [Abstract][Full Text] [Related]
37. Estradiol antagonism of glucocorticoid-induced GILZ expression in human uterine epithelial cells and murine uterus.
Whirledge S; Cidlowski JA
Endocrinology; 2013 Jan; 154(1):499-510. PubMed ID: 23183181
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
[TBL] [Abstract][Full Text] [Related]
39. RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).
Nagini S
Anticancer Agents Med Chem; 2012 Sep; 12(7):718-25. PubMed ID: 22292753
[TBL] [Abstract][Full Text] [Related]
40. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
